Comparative study of taste disturbance by losartan and perindopril in healthy volunteers

Journal of Clinical Pharmacology

Volumn 45, Issue 11, 2005, Pages 1319-1323

  Tsuruoka, Shuichi ^a   Wakaumi, Michi ^a   Araki, Nobutaka ^a   Ioka, Takashi ^a   Sugimoto, Kohichi ^a   Fujimura, Akio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adverse drug reactions; Angiotensin II receptor blockers; Angiotensin converting enzyme inhibitor; Dysgeusia; Gustometry

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; PERINDOPRIL; PLACEBO; RENIN; ZINC;

ADULT; ARTICLE; BITTER TASTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DEVICE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ELECTROGUSTOMETRY; HUMAN; HUMAN EXPERIMENT; JAPAN; MALE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; RANDOMIZED CONTROLLED TRIAL; TASTE; TASTE DISORDER;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; LOSARTAN; MALE; MIDDLE AGED; PERINDOPRIL; RENIN; SALIVA; TASTE THRESHOLD; ZINC;

EID: 27244441308     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270005280445     Document Type: Article

References (15)

1. Henkin RI. Drug-induced taste and smell disorders: incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Safety. 1994;11:318-377.
2. Tomita H, Yoshikawa T. Drug-related taste disturbances. Acta Otolaryngol Suppl. 2002;546:116-121.
3. Heyneman CA. Zinc deficiency and taste disorders. Ann Pharmacother. 1996;30:186-187.
4. Schlienger RG, Saxer M, Haefeli WE. Reversible ageusia associated with losartan. Lancet. 1996;347:471-472.
5. Heeringa M, van Puijenbroek EP. Reversible dysgeusia attributed to losartan. Ann Intern Med. 1998;129:72.
6. Tsuruoka S, Wakaumi M, Nishiki K, et al. Subclinical alteration of taste sensitivity induced by candesartan in healthy subjects. Br J Clin Pharmacol. 2004;57:807-812.
7. Andersen NH, Mogensen CE. Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease. Curr Hypertens Rep. 2004;6:369-376.
8. Meret S, Henkin R. Simultaneous direct estimation by atomic absorption spectrophotometry of copper and zinc in serum, urine, and cerebrospinal fluid. Clin Chem. 1971;17:369-373.
9. Heise C. Measurement of plasma renin activity. Clin Chem. 1975;21:447-449.
10. Tomita H, Ikeda M, Okuda Y. Basis and practice of clinical taste examinations. Auris Nasus Larynx. 1986;13(suppl 1):S1-S15.
11. Lees KR, Reid JL. Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man. Br J Clin Pharmacol. 1987;23:159-164.
12. Ohtawa M, Takayama F, Saitoh K, Yoshinaga T, Nakashima M. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans. Br J Clin Pharmacol. 1993; 35:290-297.
13. Takai S, Jin D, Sakaguchi M, Miyazaki M. Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors. Hypertens Res. 2004;27:213-219.
14. Gilbertson T, Damak S, Margolskee R. The molecular physiology of taste transduction. Curr Opin Neurobiol. 2000;10:519-527.
15. Lindemann B. Receptors and transduction in taste. Nature (Lond). 2001;413:219-225.